Norwegian version of this page

K.G. Jebsen Centre for Cancer Immunotherapy

A Translational Research Program for the Development of New Strategies for Immunotherapy Against Cancer


Our overall focus is to develop novel technologies and immunotherapeutic strategies that overcome immunological tolerance to cancer. In particular, we will focus on leukemia and lymphoma.


News and Events

  • Prestigious grant for JCIT researchers Goodridge and Malmberg Feb. 13, 2018 8:04 AM

    Jodie Goodridge and Karl-Johan Malmberg have received a grant from The Research Council of Norway (RCN) Toppforsk for the project "Programming natural killer cell function through the organelle communication". Their application was among the 16% that was granted.


The centre was established by a generous donation from Stiftelsen Kristian Gerhard Jebsen.